KYLE, TX–(Marketwire – September 9, 2010) –  CommuniCare Health Centers, a Federally Qualified Health Center that provides health care in Bexar and Hays Counties, announced today that it has received a $56,533 grant from the Austin Affiliate of Susan G. Komen for the Cure®. The grant will provide low-income, uninsured women in Hays County with greatly needed educational information about breast cancer, access to clinical breast exams, and mammograms.

“We are so pleased to receive the grant from the Austin Affiliate of Susan G. Komen for the Cure® and look forward to making breast health services available to more women in Hays County,” said Debbora A. Thompson, Chief Executive Officer of CommuniCare Health Centers. “Without organizations like the Komen Foundation many low-income, minority, uninsured women would not have access to critical breast health screenings.”

The services provided by the grant will be offered to uninsured women aged 40 to 64 at CommuniCare’s health center at 1340 Wonder World Drive in San Marcos and at its new health center in Kyle, CommuniCare Health Centers – Kyle at 2810 Dacy Lane. To access services funded by this grant, please call 512.392.1718. CommuniCare will be opening CCHC-Kyle, on September 20, 2010 where medical, dental and behavioral health care will be available to area residents. 

About the Austin Affiliate of Susan G. Komen for the Cure:
The Austin Affiliate of Susan G. Komen for the Cure® has been working to better the lives of those facing breast cancer in the Greater Austin community since 1999. Through events such as the Komen Austin Race for the Cure® and other philanthropic endeavors, the Austin Affiliate has invested nearly $7 Million in community breast health programs in Bastrop, Caldwell, Hays, Travis, and Williamson Counties. The Affiliate makes grants to local hospitals and community organizations that provide breast health education and breast cancer screening and treatment programs for medically underserved women.
For more information on the Austin Affiliate of Susan G. Komen for the Cure® please visit www.komenaustin.org.

About CommuniCare:
CommuniCare Health Centers (CCHC) has served San Antonio for over 38 years. CCHC provides medical, dental and behavioral health services to uninsured and underserved residents in Bexar and Hays counties and delivered more than 151,000 visits in 2009 in two health centers in San Antonio and one in San Marcos. As a non-profit community health center, it serves those with Medicaid, Medicare, medical insurance and those that do not have insurance, charging on a sliding-fee scale based on annual household income and family size. For more information on Barrio Comprehensive Family Health Care Center, Inc. dba CommuniCare Health Centers please visit www.communicaretx.org.

DENVER, CO–(Marketwire – September 9, 2010) –  The Breakaway Group will host an exclusive group of healthcare leaders, educators and innovators at the Inverness Hotel & Conference Center in Denver, from September 23-25, for the 2010 Healthcare Forum: Beyond Implementation, The New Leadership Agenda for Lasting EMR Adoption. Featuring a presentation by Wil Yu, Special Assistant, Innovations and Research, Strategic Health IT Advanced Research Projects, Office of the National Coordinator for Health IT, the central theme of the forum centers on the changing leadership agenda for three roles in healthcare: the CEO, CIO and Clinical Leadership.

Attendees and presenters include top leaders from Trinity Health, UT Medical Group, Arkansas Children’s Hospital, Baptist Health System and Hartford Health Care, and others. The 2010 Healthcare Forum continues the conversation launched in 2007 at the Healthcare Summit in Vail, Colo., where discussion focused on the challenge of how to treat an HIT implementation as more than a single event. 

“The Healthcare Forum provides a way for C-level executives to collaborate on finding successful ways to shift leadership priorities, to refocus organization efforts around EMR adoption,” said Charles Fred, chief executive officer of The Breakaway Group. “We are excited to offer the results of our research as a way to facilitate meaningful use and sustainable EMR adoption in the healthcare industry.” 

Recent Research Serves as Foundation for New Leadership Agenda
In the face of increased pressure to adopt new technology, healthcare executives have been led to reprioritize their everyday roles. Recent in-depth research from The Breakaway Group into the major barriers of EMR adoption and improved clinical outcomes (Beyond Implementation: A Prescription for Lasting EMR Adoption, 2010, Haugen, H., Woodside, J.) will serve as a foundation for the leadership agenda discussion. 

The authors, Dr. Heather Haugen and Dr. Jeffrey Woodside, M.D., conducted more than 18 months of research with leaders and healthcare organizations representing more than 3,200 physicians and 350 ambulatory sites. Through case studies and research, they examine why the transition to EMR is often overly costly, lengthy and frustrating.

“Despite the significant benefits of electronic medical records, healthcare organizations are not seeing the financial and clinical outcomes they had hoped for,” said Dr. Haugen, co-author of Beyond Implementation. “After investigating the outcomes of poor adoption and why physicians don’t get the full potential from EMR, we have identified one common thread. Too often, the primary focus is on go-live implementation when instead, this step should be the beginning of a sustained effort for the life of the application.”

About The Breakaway Group
The Breakaway Group helps healthcare providers quickly adopt new technology through a research-based method that uses innovative simulations and coaching to help improve patient care and safety. The firm’s unique approach to learning is based on the best-selling book “Breakaway” by CEO and Founder Charles Fred. For more information, visit www.thebreakawaygroup.com.

PT. HUENEME, CA–(Marketwire – September 9, 2010) –  Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) announces filing for patent protection of inventions related to its native Immunogenic (IMG) KLH technology platform and immune status monitoring product portfolio. KLH (keyhole limpet hemocyanin) is presently the most pharmaceutically important ICP (immune carrier protein) and IMG KLH is the most effective immune stimulant for use in cancer, viral and parasite vaccines; animal vaccines; and diagnostic products. Patent claims include pharmaceutical grade compositions of matter, processes for manufacture and methods of use in a wide range of therapies.

John Sundsmo, Ph.D., VP Research and Intellectual Property, said, “With filing of this patent application Stellar has achieved an important milestone on the road to becoming the preeminent world leader in development and manufacture of pharmaceutical grade immune carrier proteins. We are very pleased with the progress achieved by our scientists and what this patent application tangibly demonstrates.”

Corporate Website: www.StellarBiotechnologies.com
Stellar News at Marketwire: http://www.marketwire.com/mw/search.do?params=&grpSearch=C&companyid=70788

About Stellar Biotechnologies, Inc. (PINKSHEETS: SBOTF) (TSX-V: KLH) – (www.StellarBiotechnologies.com): is a world leader in sustainable manufacturing of pharmaceutical grade immune carrier proteins (ICP), particularly with regard to the present most important pharmaceutical protein in this class, KLH (Keyhole Limpet Hemocyanin). This ancient evolutionary protein has a highly complex structure that makes it ideal for use in human and animal vaccines and diagnostic products. With partners and customers, its flagship Stellar KLH products are in the clinic, and on the way to being established as the only sustainable, long-term pharmaceutical source.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy any of the Company’s securities set out herein in the United States, or to, or for the benefit or account of, a U.S. Person or person in the United States. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

MADISON, WI–(Marketwire – September 9, 2010) – TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced, integrated radiation therapy solutions for cancer care, today announced that its technology will soon be used to treat cancer patients in Nottingham, England. The Nottingham Radiotherapy Centre will install the TomoTherapy^® Hi·Art^® treatment system in November as part of a service expansion and relocation. 

The TomoTherapy treatment system enables delivery of state-of-the-art CT image-guided intensity modulated radiotherapy (IG-IMRT), enabling the hospital to reinforce its leadership in high-quality, efficient cancer care for the people of the East Midlands of England.

The Nottingham Radiotherapy Centre serves a population of approximately 1 million and delivers 37,000 fractions of radiation therapy annually. The Centre provides complex external beam treatment including paediatric radiation therapy, intensity-modulated radiation therapy (IMRT), continuous hyperfractionation, and total body electron and photon radiation therapy. The centre is part of Nottingham University Hospitals National Health Service (NHS) Trust, which is one of the country’s largest teaching hospitals.

Russell Hart, Radiotherapy Service Manager of the Centre, states:

“Our multi-disciplinary team is thrilled to be introducing TomoTherapy technology. Benefits will include better access for our patients to what we believe is the best delivery system for complex image-guided, intensity-modulated radiation therapy (IG-IMRT). The new machine will also mean that there will be some patients for whom curative treatment will now be possible whereas in the past treatment would only have been offered on a palliative basis. A clear advantage of the TomoTherapy system is the rapid installation time. This will enable us to have the high technology available in a short space of time — much quicker than a conventional linear accelerator.

Here at Nottingham, in line with national policy, we believe that four-dimensional (4D) Adaptive Radiotherapy is the future standard of care for radiotherapy treatment, and that the TomoTherapy Hi·Art system is the most sophisticated and best system to achieve this objective. We believe our equipment strategy will provide us with a full range of treatment options for the population we serve, with the TomoTherapy system best able to deliver the most complex dose distributions.”

Commenting on the key role TomoTherapy technology is playing in a publicly funded health service, Julie Mead, Director and Clinical Advisor from Oncology Systems Limited, states:

“The oncology team at Nottingham put all equipment vendors through a rigorous clinical and technical public tender evaluation. They clearly concluded that the TomoTherapy platform would bring significant benefits to a centre that is reported as having one of the busiest patient throughput figures per treatment machine, in all of the UK. Already having a linac IMRT programme in place, the Nottingham Radiotherapy Centre also saw the improvement in treatment quality that TomoTherapy technology would bring, along with centre-wide efficiency gains from allocating advanced treatments to the unit. In difficult financial times, the TomoTherapy platform offers not only the best quality radiotherapy, but also the highest efficiency for advanced IG-IMRT. The NHS looks at cost-effectiveness as a key criterion. The TomoTherapy platform fits the bill.”

Reinforcing the efficiency requirements so critical to the publicly funded NHS, Nottingham’s Russell Hart adds:

“We treat between 35 to 50 patients per normal working day on our linear accelerators, depending on the complexity of the work being undertaken. We aim to maintain that throughput and utilise TomoTherapy technology to its maximum, by treating up to 35 patients per day. Other NHS TomoTherapy customer sites have demonstrated that this is possible in the UK, but of course this will be a tremendous achievement in Nottingham as we clearly expect that the treatments delivered on the TomoTherapy unit will have far higher quality and complexity than what is feasible on the linear accelerator it is replacing.”

TomoTherapy technology is developed and manufactured by TomoTherapy Inc., and is supplied in the UK by Oncology Systems Limited, based in Shrewsbury, England.

About Nottingham University Hospital
Nottingham City University Hospital NHS Trust (NUH) is one of England’s busiest and largest acute teaching trusts. It provides acute and specialist services to 2.5 million people within Nottingham and surrounding communities from the Queen’s Medical Centre and the City Hospital campuses. The hospital’s annual budget is in excess of £682 million of public sector funding, housing over 1,700 hospital beds and employing over 13,000 staff.

Nottingham is the only city in the country to secure three successful bids for prestigious biomedical research units. NUH is working with The University of Nottingham to help to translate research findings for stomach, bowel and liver disease, hearing and respiratory disease into better patient care.

About Oncology Systems Limited
Oncology Systems Limited (OSL) is a privately owned limited company based in Shrewsbury, England. OSL is an exclusive supplier of radiation therapy technology to the UK and Ireland. It distributes TomoTherapy^® cancer treatment technology to the UK’s NHS and private radiotherapy facilities, and to both public and private providers in the Republic of Ireland.

About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy^® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy’s suite of solutions include its flagship Hi·Art^® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD^™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile^™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

©2010 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, TomoDirect, TQA, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

SCOTTSDALE, AZ–(Marketwire – September 9, 2010) – Top 10 women’s health site EmpowHER today launched what is expected to be the largest online movement for women’s health in the next year — the 1000Women campaign.

Expecting to engage 1,000 women who will each recruit another 1,000 women to participate in this classic pay-it-forward viral effort; the campaign’s goal is to get 1 million women to share their inspirational health stories with friends, family, and women they’ve never even met. Campaign participants can do this by creating profiles on 1000Women.com where they can: “tell a friend” about the campaign; share their own personal health and wellness story — including pictures and videos if they wish, or simply vote for another woman’s story that inspires them.

When 1 million women have engaged in the campaign, EmpowHER will donate $50,000 toward women’s health research.

“Participants in this campaign are not required to spend a penny. Every time a new woman signs up to share a story, vote for a story, or share the campaign with others, money will be donated by EmpowHER to fund women’s health research,” said Thom Brodeur, Chief Marketing Officer for EmpowHER and campaign architect. “Our challenge to women is simple. Open your hearts, log onto the website, and pass it along. We’ll open our wallet and do the rest. We’re partnering with women to improve their health and change their lives, and we’re honored to play a role.”

The majority of campaign funds will be donated to HealthyWomen, the nation’s leading nonprofit health information source for women. For more than 20 years, HealthyWomen has been committed to improving women’s health through public education campaigns grounded in research among women nationwide.

“Studies show that when women share their health issues with other women, their state of mind improves, sometimes even having positive effects on their overall health,” said Jay K. Harness, MD, a member of EmpowHER’s Medical Advisory Board, President of Breast Surgery International and breast surgeon in Orange County, Calif. “For example, a recent report from the California HealthCare Foundation reported that when patients managing the same chronic condition share observations with each other, their collective wisdom can yield clinical insights well beyond the understanding of any single patient or physician.”

Dr. Harness, past president of the American Society of Breast Surgeons, goes on to say, “Studies have found that cancer patients who were isolated and lacked social interaction had greater tumor growth and worse prognosis. We firmly believe that loneliness and isolation can have a significant impact on a patient’s long-term battle with a disease.” Dr. Harness concluded that online communities are a great resource for patients to share and connect, but are not a substitution for oversight and guidance from a patient’s medical team.

“Women need to advocate for themselves and each other by calling for more gender-specific health research,” said Michelle King Robson, Founder, Chairperson and CEO of EmpowHER. “Much of the world’s health-related research remains male dominated, signaling there is still much to learn about women’s unique health conditions and the specific effects of procedures, drugs and diagnostics on women. This campaign was created to give women a voice in their own health, and to provide financial support to organizations dedicated to advancing women’s health research and advocacy.”

King Robson has witnessed this trend first-hand. Her site, launched just 24 months ago, reaches nearly 1.2 million unique visitors and viewers every month from women sharing their most intimate health conditions and then connecting with others for support. “I started this site after I experienced my own health nightmare and began telling my story. What has occurred has been a firestorm of other women who have found solace and better health by sharing on EmpowHER.com. We now want to take this to a new level of connectivity for all women around the globe by giving them a voice in their health through this campaign.”

To participate in the 1000Women Campaign, please visit www.1000Women.com.

About EmpowHER
EmpowHER is an award-winning health media company for women. The Company’s website provides visitors access to one of the largest women’s health and wellness content libraries on the web, as well as the largest online community of women discussing their health and wellness issues. EmpowHER promotes a “24 Hour Promise” to its visitors, who can come to the site, ask any health question and receive a response within 24 hours. Health care marketers rely on EmpowHER for reaching the most influential health and wellness buying audience on the Internet — women. Millions of women visit EmpowHER.com every year, making it one of the largest and fastest-growing resources dedicated exclusively to women’s health and wellness. For more, visit www.EmpowHER.com.

About HealthyWomen
HealthyWomen (HW) is the nation’s leading independent health information source for women. For more than 20 years, women have been coming to the HW for answers to their most pressing and personal health care questions. HW provides health information through a wide array of online content and print publications that are original, objective and reviewed and approved by medical experts. Its website, www.HealthyWomen.org®, was recognized by ForbesWoman as one of the “Top 100 Websites for Women” and was named the top women’s health website by Dr. Mehmet Oz in O, The Oprah Magazine and by Good Housekeeping magazine. To learn more, visit www.HealthyWomen.org.

id=”nav_links”>

CHICAGO, IL–(Marketwire – September 8, 2010) –  Graham Czach‘s wild creativity and unique versatile sound have earned the Windy City native a nomination for The Deli Chicago’s Artist of the Month. Fans can vote online through September 15 by clicking http://chicago.thedelimagazine.com/snacks.

The socially conscious rocker (www.grahamczach.com) is also teaming up with Planned Parenthood of Illinois (PPIL) to celebrate the official release of his independent debut album Lucid on Friday, October 15 at Martyrs (3855 North Lincoln Ave.) in Chicago. The show begins at 9:30 p.m. Tickets are $12 and may be purchased at www.martyrslive.com or at the door.

With a Chicago Music Award under his belt, the versatile singer/songwriter and multi-instrumentalist will bring his modern and progressive rock sensibilities to life performing with the album’s original band members: drummer Kris Myers (Umphrey’s McGee), keyboardist Matt Nelson (Lupe Fiasco, Matthew Santos), guitarist Chris Siebold (Howard Levy, Kick the Cat) and bassist Graham Burris (Lupe Fiasco, Matthew Santos).

Czach — whose album includes a powerful song about abortion rights titled “Choice” — is donating a portion of sales generated from the event to PPIL. PPIL’s 17 health centers throughout the state deliver comprehensive reproductive health care services, sex education, and sexual health information to more than 60,000 women, men, and teens each year.

In addition to Planned Parenthood of Illinois, a portion of the proceeds from Lucid is being donated to other non-profit organizations including Greenpeace, the American Cancer Society and the Art of Living Foundation.

As Lucid sheds light on these important social issues and more, Czach draws on a fascinating, diverse musical background — which includes his work with Chicago Afrobeat Project — to create musical landscapes as compelling as the lyrics. He was recently interviewed by Skope Magazine‘s editor Mike Friedman and by Lisa Smith of The Blend Magazine for their Take Action Party surrounding his earth-friendly messages.

Tapping into his childhood where Led Zeppelin, The Beatles and Crosby, Stills, Nash & Young were practically a religion, and later influences like Pink Floyd, Red Hot Chili Peppers, The Mars Volta and Jimi Hendrix, he infuses hard rocking, sometimes unusually metered grooves to four (and more) part vocal harmonies, beautiful acoustic melodies and vibrant unfolding string arrangements.

Click here to see all recent news from this company

MUNDELEIN, IL–(Marketwire – September 8, 2010) –  A little over a year after Medline Industries, Inc., the largest privately held manufacturer and distributor of healthcare supplies in the U.S., completed and opened its new environmentally conscious service facility center in Dubuque, Iowa, the building officially received Leadership in Energy and Environmental Design (LEED) silver certification.

LEED is an internationally recognized, third party validation system of certification for many buildings. It measures and evaluates design, construction, operation and maintenance solutions. LEED is generally viewed as a trusted benchmark for a building’s impact on the environment.

In order to receive this certification, Medline applied and the building was then evaluated by LEED, who allocated points based on preset green criteria — focusing on energy efficiency and CO₂ reduction. There are seven areas on which LEED evaluated the service facility: sustainability of the site, water efficiency, energy and atmosphere, materials and resources, indoor environmental quality, location and linkages, awareness and education, innovation in design and regional priority. To achieve silver certification, the second highest certification category, the service facility was awarded points that placed them in the 60-79 point range out of a 100-base point system. 

“The building was constructed with the environment and LEED certification in mind,” said Robert Abrams, the Corporate Director who oversaw the project. “Some of the green aspects of the 66,000-square-foot facility are daylight harvesting energy-efficient lighting, solar-tracking skylights, technologically advanced building insulation materials, tankless hot water heaters and a geothermal heating system.”

The installation of these and other green technologies resulted in an electrical use reduction of 320,565 kWh, which avoids more than 230 metric tons of carbon dioxide. This is equivalent to removing the CO₂ emissions from 26,131 gallons of gasoline consumed or 535 barrels of oil consumed. All of this gathered points for certification as well as small things, such as close parking for a Prius, cubical walls made with recycled fabric that traveled less than 500 miles from their manufacturer and energy efficient trash management. 

“I think it demonstrates Medline’s commitment to the environment as a company, and it was important for our customers,” Abrams said. “We’re being asked more and more what we’re doing to reduce our carbon footprint.”

About Medline Industries, Inc. 
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

BETHESDA, MD–(Marketwire – September 8, 2010) –  Coventry Health Care, Inc. (NYSE: CVH) announced today that John Stelben, Interim Chief Financial Officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York, New York, at 1:00 p.m. ET on Monday, September 13, 2010. 

The public may access a live webcast of the presentation on the Investor Relations page of Coventry’s website at www.coventryhealthcare.com. A replay of the presentation will be available at the same website following the presentation until Monday, September 20, 2010.

Coventry Health Care (www.coventryhealthcare.com) is a diversified national managed healthcare company based in Bethesda, Maryland, operating health plans, insurance companies, network rental and workers’ compensation services companies. Coventry provides a full range of risk and fee-based managed care products and services to a broad cross section of individuals, employer and government-funded groups, government agencies, and other insurance carriers and administrators.

RALEIGH, NC–(Marketwire – September 8, 2010) –  InoLife Technologies, Inc. (OTCBB: INOL), a service based healthcare products development, integration and marketing Company, is extremely pleased that their recently presented Cytochrome P450 2C1 test to determine a person’s ability to metabolize Plavix is immediately available to the medical industry which includes physicians, hospitals, medical clinics, and pharmacies. Physicians are currently placing orders on a daily basis and are incorporating the Cytochrome P450 2C1 Plavix Metabolizing test into their patients health programs. 

InoLife’s Cytochrome P450 2C1 test is currently being used to identify how a patient’s genetics may affect the body’s response to Plavix (Clopidogrel). The test is available through the medical community only including physicians, hospitals, and medical clinics. This test is not available for sale to the general public.

According to the FDA in a press release dated March 12^th, 2010 it is estimated that 2 percent to 14 percent of the U.S. population are poor metabolizers of certain medications. In 2009 the Federal Drug Administration approved wording on the drug label encouraging genetic testing for DNA variants based on specific risks. It is important to note that this drug metabolism test is not all-inclusive and is for the physician’s guidance only.

InoLife has incorporated the EasiCollect™ System, which combines an optimized foam collection surface with an FTA card for collection of buccal cells and preservation of DNA. InoLife prides itself in providing the EasiCollect™ System that adheres to the strict guidelines of the Clinical Laboratory Improvement Amendments (CLIA) that monitors approximately 200,000 laboratory entities. The Center for Medicare & Medicaid Services regulates all laboratory testing (except research) performed on humans in the U.S. through CLIA.

About InoLife Technologies, Inc.
InoLife is poised to become one of the premier U.S. marketers of state-of-the-art DNA-based test products. Positioned for growth and success in a burgeoning market, InoLife Technologies, www.inolifetech.com, is primarily focused on products, services and solutions that will enable state-of-the-art healthcare for today and the future for a diverse base of customers and end users. The Company’s mission is to identify, develop, integrate and bring to market innovative healthcare-based products and services that provide timely and practical solutions. The primary products and services that InoLife is currently addressing focuses upon those specific products and services that provide key solutions through the innovative use of specific DNA testing and Genetic analysis systems.

The principal customers of InoLife’s products and services are healthcare providers, physicians, practitioners, hospitals and outpatient facilities. InoLife will be marketing and distributing its products through traditional distribution channels. Additionally InoLife has developed certain products that can be sold directly to consumers and has created specific programs to reach those customers including e-commerce, direct sales, healthcare providers, pharmacies, distributors, retail sellers and specialty retailers.

(Plavix is a trademark of Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.)

Forward-Looking Statements
Safe Harbor Statement under the Private securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company’s control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission.

VANCOUVER, BRITISH COLUMBIA–(Marketwire – Sept. 8, 2010) – ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCQB:APCSF) (the “Company”) is pleased to announce that it has closed the private placement announced July 27^th, 2010. A total of 3,275,000 Units of the Company were issued at a price of $0.10 per Unit for gross proceeds of $327,500. All securities issued with respect to the private placement will be subject to a hold period expiring on January 8, 2011 in accordance with the policies of the TSX Venture Exchange and applicable Canadian securities laws. 

Each Unit consists of one common share of ALDA and one non-transferable share purchase warrant entitling the holder to acquire one additional common share of ALDA at a price of $0.20 per common share for a period of two (2) years from the date of the issuance of the purchase warrant with a forced exercise provision attached to each warrant commencing on the day following the expiry of any applicable hold period on the underlying Common Share, stating that if, for ten consecutive trading days, the closing price of the listed shares of the Company exceeds $0.40 then the exercise period of the warrants will be reduced to a period of 10 days following such trading days. Net proceeds from the offering will be used for working capital.

The Company paid finders’ fees of $2,250 (5% of the gross proceeds of $45,000) to certain registrants with respect to the offering.

Insiders of ALDA subscribed for 677,500 Units on the same terms as arm’s length investors, constituting a related party transaction pursuant to Multilateral Instrument 61-101 and TSX Venture Exchange Policy 5.9. Such Insider participation was exempt from the requirement to obtain an independent valuation pursuant to Section 5.5(b) of MI 61-101 and the requirement to obtain minority shareholder approval pursuant to Section 5.7(1)(b) of MI 61-101.

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived from its patented T³6^® technology. The company trades on the TSX Venture Exchange under the symbol APH and on the OTCQB under the symbol APCSF. The Company was the Official Supplier to the Vancouver 2010 Olympic Winter Games and the Vancouver 2010 Paralympic Winter Games and is the Official Supplier to the Canadian Olympic Committee, the 2010 Canadian Olympic Team and the 2012 Canadian Olympic Team for antiseptic hand sanitizer, disinfectant and disinfectant cleaning products. The Company was also selected as one of the TSX Venture 50 companies in the Technology and Life Sciences sector for 2010.

Terrance G. Owen, Ph.D., MBA
President & CEO
ALDA Pharmaceuticals Corp.
www.aldacorp.com

The Units, common shares, warrants and the common shares issuable upon exercise of the warrants have not been registered under the United States Securities Act of 1933 (the “Act”) and may not be offered or sold absent registration under the Act or an applicable exemption from the registration requirements thereof. This news release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction or an exemption therefrom.

Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA’s expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as “outlook”, “will”, “could”, “would”, “might”, “remains”, “to be”, “plans”, “believes”, “may”, “expects”, “intends”, “anticipates”, “estimate”, “future”, “plan”, “positioned”, “potential”, “project”, “remain”, “scheduled”, “set to”, “subject to”, “upcoming”, and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.

CINCINNATI, OH–(Marketwire – September 8, 2010) –  Compass Clinical Consulting features Jim Anderson, Chief Executive Officer of Cincinnati Children’s Hospital Medical Center (1996-2010), in a newly published, in-depth monograph on leadership excellence in healthcare.

LONG AGO AND FAR AWAY

In 1996, Cincinnati Children’s Hospital Medical Center (CCHMC) had 3,500 employees, 365,000 yearly patient encounters and $453 million in revenue. At the time, the hospital was looking for a new CEO to transform, grow and lead the organization into an uncertain future.

SAFE & OBVIOUS CHOICE

The safe and obvious selection would have been a candidate with extensive hospital administration training and long-term, proven leadership experience.

But, the CCHMC Board chose exactly the opposite.

A LAWYER … WITH A LEAN MANUFACTURING BACKGROUND?

They selected a lifelong attorney with a manufacturing executive background — a lawyer with an entrepreneurial bent and appreciation of lean manufacturing principles — James M. Anderson.

AND THAT MADE ALL THE DIFFERENCE

In all measures, the hospital’s success and growth under Jim Anderson’s visionary leadership was extraordinary. When he retired at the end of 2009, CCHMC had grown to over 11,000 employees, 925,000 yearly patient encounters and $1.6 billion in revenue. Under Mr. Anderson’s leadership CCHMC was transformed from a small regional hospital serving the greater Cincinnati area into an internationally recognized leader in improving healthcare outcomes, experience and results for children.

HOW DID IT HAPPEN?

To learn more, read the newly published Compass Clinical Consulting “Profiles in Healthcare Leadership” monograph, featuring hard-won lessons from Jim Anderson’s career at CCHMC.

Key Lessons for Hospital Leaders:

• How setting a goal at zero defects changes your aspirational framework and exemplifies the extraordinary commitment required of patient- and family-centered care
• What to do when your best people tell you it can’t be done — and how to do it anyway, saving lives
• Lead with lawyers to reduce hospital, healthcare and legal costs
• How to build an Entrepreneurial Healthcare Organization
• One simple message to align the workforce and leadership

Compass Clinical Consulting’s “Profiles in Healthcare Leadership” are the products of interviews with transformational leaders in today’s healthcare industry — all of whom have demonstrated courage, ingenuity and the hard work needed to create dramatic, measurable and sustainable improvements in healthcare. These featured leaders challenge assumptions, see things differently and create remarkable breakthroughs.

DOWNLOAD your copy of Profiles in Healthcare Leadership: An Interview with Jim Anderson

About:
Compass Clinical is a healthcare consultancy founded in 1979 and based in Cincinnati, OH. Compass experts have helped hundreds of hospitals and health systems prepare for accreditation, optimize labor cost management, manage clinical resources, and improve patient throughput and physician relations. Compass also places interim healthcare executives.

DENVER, CO–(Marketwire – September 7, 2010) –  Eating Recovery Center (www.EatingRecoveryCenter.com) today announced that two of the nation’s foremost eating disorders experts have joined its executive team. Craig Johnson, PhD, FAED, CEDS, has been named chief clinical officer of Eating Recovery Center and Ovidio Bermudez, MD, FAAP, FSAM, FAED, CEDS, will become the medical director of Eating Recovery Center’s new child and adolescent treatment program. The appointments of these renowned doctors, known for their scholarship, dedication and clinical expertise, further elevate Denver, Colo., as the nation’s hub for eating disorders treatment.

Eating Recovery Center, a national center for eating disorders recovery providing comprehensive treatment for anorexia and bulimia, currently operates a licensed behavioral hospital for adults with serious eating disorders and an outpatient office, both located in Denver, Colo.

“Eating disorders impact 11 million Americans and remain the deadliest mental illnesses,” said Kenneth L. Weiner, MD, CEDS, founding partner and chief executive officer of Eating Recovery Center. “With the addition of Drs. Johnson and Bermudez, Eating Recovery Center has assembled an internationally renowned team to help patients tackle every level of care from critical inpatient care to outpatient treatment.”

As chief clinical officer, Dr. Johnson will direct Eating Recovery Center’s clinical program development and implementation. He will also drive the Center’s research efforts in conjunction with Emmett R. Bishop, Jr., MD, CEDS, founding partner and medical director of adult services of Eating Recovery Center. A leader in the field of eating disorders treatment since 1979, Dr. Johnson founded and was most recently the director of the Eating Disorders Program at Laureate Psychiatric Hospital in Tulsa, Okla. He is a professor of psychiatry at the University of Oklahoma Medical School and has formerly held faculty appointments at the University of Chicago and Northwestern University Medical Schools. 

Dr. Johnson was the founding editor of the International Journal of Eating Disorders, as well as a founding member of both the Academy of Eating Disorders and the Eating Disorders Research Society. He is also past president of the National Eating Disorders Association. He has authored three books, more than 70 scientific articles, and has been the recipient of several distinguished contribution awards.

“Eating Recovery Center’s ability to quickly adapt treatment innovations has led to the organization becoming a leader in the field of eating disorders. I look forward to working with this distinguished group to further advance the field,” said Dr. Johnson.

Dr. Bermudez, nationally and internationally recognized as an expert in the treatment of adolescents with eating disorders, will apply his expertise to the development of Eating Recovery Center’s new child and adolescent treatment program. Most recently the medical director of Laureate’s Eating Disorders Program, Dr. Bermudez is co-founder of the Eating Disorders Coalition of Tennessee (EDCT), vice-president and co-founder of the Oklahoma Eating Disorders Association (OEDA), as well as past president of the National Eating Disorders Association. He also serves in several leadership positions within the Academy for Eating Disorders.

Dr. Bermudez holds an academic appointment as clinical professor of psychiatry and pediatrics at the University of Oklahoma College of Medicine. He was previously faculty at the Vanderbilt University School of Medicine. Additionally, he is a Certified Eating Disorder Specialist and member of the International Association of Eating Disorders Professionals. Dr. Bermudez has lectured nationally and internationally on eating disorders, childhood obesity and other topics related to adolescent healthcare. He has been widely recognized for his dedication and advocacy on behalf of sufferers and families.

“I am thrilled to join the clinical team at Eating Recovery Center to develop an innovative program focused on the specialized needs of children and adolescents with eating disorders,” said Dr. Bermudez. “Our approach will be sensitive to the developmental needs of each patient and address the medical, behavioral and psycho-social aspects of their eating disorder while working closely with each family — all important components of successful treatment and lasting recovery.”

Denver, Colo., now offers individuals with eating disorders a full spectrum of care overseen by the nation’s leading eating disorders clinicians. Drs. Johnson and Bermudez join Eating Recovery Center founders, Drs. Weiner and Bishop, recognized experts with more than 50 years combined expertise, in providing inpatient, residential, partial hospitalization, intensive outpatient and outpatient services at Eating Recovery Center’s facilities. A partnership with Denver Health’s A.C.U.T.E. eating disorders program, directed by Philip Mehler, MD, CEDS, an expert in the medical complications of eating disorders, enables Eating Recovery Center to collaboratively provide care for severely medically compromised eating disorders patients.

About Eating Recovery Center
Eating Recovery Center is a national center for eating disorders recovery providing comprehensive treatment for anorexia and bulimia. Denver-based facilities include a licensed behavioral hospital treating adults, an outpatient office and a facility treating children and adolescents scheduled to open in November 2010. Under the personal guidance and care of Drs. Weiner and Bishop, and the newest additions to our leadership team — Drs. Craig Johnson and Ovidio Bermudez, our collaborative programs provide a full spectrum of services for children, adolescents and adults. Our integrated program offers patients from across the country a continuum of care that includes inpatient, residential, partial hospitalization, intensive outpatient and outpatient services. Our compassionate team of professionals collaborates with treating professionals and loved ones to cultivate lasting behavioral change. For more information please contact us at 877-218-1344 or [email protected] or confidentially chat live on our website at www.EatingRecoveryCenter.com.

Click here to see all recent news from this company

UTICA, NY–(Marketwire – September 7, 2010) –  CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for surgical and patient monitoring markets, announced today that the Company will participate in three investor conferences during the second week of September 2010 as follows:

• Morgan Stanley Global Healthcare Conference on September 14, 2010 at 3:20 PM Eastern, in New York City

• CL King Best Ideas Conference on September 15, 2010 at 2:45 PM Eastern, in New York City

• Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 at 2:40 PM Eastern, in Boston

Mr. Joseph J. Corasanti, President and CEO of CONMED, will discuss the Company’s business. The live webcasts of CONMED’s presentations will be available at www.conmed.com in the Investor Relations – Events Calendar section of the website and will be available for replay through September 24, 2010.

CONMED Profile

CONMED is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and patient monitoring. The Company’s products serve the clinical areas of sports medicine-arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery and endoscopic technologies. Surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology use the Company’s medical devices. Headquartered in Utica, New York, the Company’s 3,300 employees distribute its products worldwide from several manufacturing locations.

Forward Looking Information

Certain statements made in the presentations may constitute forward-looking statements. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. They will be based upon management’s expectations and involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements therein or in previous disclosures. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to: (i) the failure of any one or more of management’s assumptions to prove to be correct; (ii) the risks relating to forward-looking statements discussed in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and Quarterly Reports on Form 10-Q; (iii) cyclical purchasing patterns from customers, end-users and dealers; (iv) timely release of new products, and acceptance of such new products by the market; (v) the introduction of new products by competitors and other competitive responses; (vi) the possibility that any new acquisition (and its integration) or other transaction may require the Company to reconsider its financial assumptions and goals/targets; (vii) increasing costs for raw material, transportation, or litigation; and/or (viii) the Company’s ability to devise and execute strategies to respond to market conditions.

TAMPA, FL–(Marketwire – September 7, 2010) – Sage North America Healthcare Division, which provides electronic health records (EHR) and practice management software and services to approximately 80,000 physicians in North America, today announced that Mayo Regional Hospital, based in Dover-Foxcroft, ME, has selected Sage Intergy EHR for the hospital’s medical practices. 

The 25-bed critical access non-profit hospital owns and operates eight physician practices. Mayo Regional Hospital selected Sage Intergy EHR following a two-year evaluation process of EHR systems in the marketplace. Sage Intergy could easily handle the hospital’s billing requirements, along with the system’s robust practice management needs, said Ben Dever, Director of Mayo Practices Associates for the Mayo Regional Hospital.

“The uniqueness of our billing system and its complexities placed Sage Intergy at the top of our vendor list,” said Dever. “In our search for an EHR, we needed a system that could handle a robust, multi-practice billing system while providing clear reporting metrics and outcomes. Intergy proved the most capable system to meet our needs.”

Sage Intergy EHR is a comprehensive clinical, financial and administrative solution that empowers physicians to advance the quality and efficiency of care they deliver. The Sage Intergy family of products includes integrated practice management, electronic health records, clinical and business intelligence and tools for online patient engagement. Providers can access Sage Intergy from multiple practice locations, from home, or other remote locations either through a central patient database server, or as a Sage-hosted solution on a monthly subscription basis. 

Sage Intergy EHR easily tracks the details of a patient’s clinical history, shares and manages clinical information and combines complex medical practice functions into easy-to-navigate menus. Sage Intergy EHR features centralized financial operations including billing, reporting, task management, and fully integrates with EDI services, Sage Intergy Practice Portal, Sage Intergy RIS and Sage Practice Analytics.

Dever said Mayo Regional Hospital is working to attain meaningful use, as driven by the federal government’s recent passing of a healthcare stimulus package. Sage Intergy EHR will provide the hospital’s practices with reporting and data collection capabilities as required by the meaningful use rules.

The clinics of Mayo Regional Hospital see more than 50,000 patients a year, and, while cost containment of moving from a paper to electronic system appealed to the hospital’s selection committee, adding Sage Intergy EHR to its healthcare system is driven by providing better quality of care, and tracking outcomes to improve treatment and care options for patients, Dever said.

“We’ll now be more easily able to track patients’ progress through their electronic records, and share patient data between the hospital and its clinics,” said Dever. “This will lead to quicker delivery of care and better, higher quality, encounters with our patients.”

Sage has been providing ambulatory healthcare systems for nearly 30 years, providing practice management solutions, electronic health records and other services to streamline patient care, as well as is a leading supplier of business management software and services, serving more than 6.2 million small and midsized business customers worldwide. 

View Sage Healthcare Division YouTube interviews.
View Sage Healthcare Division information.

About Mayo Regional Hospital
Mayo Regional Hospital is a non-profit, 25-bed critical access hospital located in Dover-Foxcroft, the county seat of Piscataquis County. Mayo Regional opened in 1978 and is governed by Hospital Administrative District 4, which was established by 12 towns to serve the healthcare needs of residents in a three-county area of rural central Maine. Mayo Hospital has 22 physicians and 375 staff members dedicated to providing acute medical/surgical care, intensive care, surgical services and obstetrics in an inpatient setting, as well as a wide array of outpatient services. Mayo Practice Associates, a department of the hospital, owns and operates eight physician practices in Corinna, Dexter, Dover-Foxcroft, Guilford and Milo.

About Sage North America
 Sage North America is part of The Sage Group plc, a leading global supplier of business management software and services. Sage North America employs 4,000 people and supports 3.1 million small and midsized business customers including approximately 80,000 physicians. The Sage Group plc, formed in 1981, was floated on the London Stock Exchange in 1989 and now employs 13,100 people and supports 6.2 million customers worldwide. For more information, please visit the website at www.sagenorthamerica.com.

© 2010 Sage Software, Inc. All rights reserved. Sage, Sage Software, Sage logos and the Sage product and service names mentioned herein are registered trademarks or trademarks of Sage Software, Inc. or its affiliated entities. All other trademarks are the property of their respective owners.

BOCA RATON, FL–(Marketwire – September 7, 2010) –  Banyan Corporation (PINKSHEETS: BNYN) announced that it has reached an agreement with Mark Eric Bailey to partner with it in the development of its America’s Dentist concept. When operational, America’s Dentist will offer a vast array of services to dental practices nationwide, including marketing; real estate/leasing support; practice management and analysis; finance; branding; practice purchase and sale representation and practice transitions.

Mark Eric Bailey has served general & specialty dentists nationwide regarding practice finance & advice at Capital4HealthCare, LLC. In 2005, he founded Dentcetera Dental Practice Advisors, LLC which provides advice, analysis and buyers representation for general & specialty dentists and in 2007 he co-founded edentalspace.com, the first global social networking site exclusively for dental professionals. Mr. Bailey has completed 463 dental practice transitions in his career. Dentcetera services will be rebranded Americas Dentist and will feature buyer’s representation or traditional practice brokerage services.

Mr. Bailey stated, “I am excited by this opportunity to participate with Banyan Corporation in the development of America’s Dentist. In today’s economy, it is more important than ever before for a dental practice to operate at its optimum, not just clinically but as a business. At America’s Dentist we will feature state-of-the-art practice management software to analyze the present business performance of a practice, and our consulting team will be able to quickly assess and recommend decisions to immediately increase a practice’s performance. Whether our services lead to the dentist’s long-term improved practice performance or help the dentist enhance practice performance in preparation for merger or acquisition, America’s Dentist services will be invaluable.”

The multi-billion dollar dental industry is the most organized of healthcare professions. Banyan Corporation believes it can leverage of the significant experience of both Mr. Bailey and its past ventures to move successfully into the dental arena.

About Banyan Corporation:

Banyan Corporation is a publicly traded holding company focused on investing in and building a network of operating subsidiaries engaged in various innovative businesses. Currently the company’s subsidiaries, Premier Medical Group, Inc. and affiliated companies, provide diagnostic testing services to physicians nationwide.

This Press Release contains or incorporates by reference forward looking statements including certain information with respect to plans and strategies of Banyan Corporation. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words “believes,” “suggests,” “anticipates,” “plans,” “expects,” and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Banyan Corporation operations that could differ materially from those indicated by such forward looking statements.

SCHAUMBURG, IL–(Marketwire – September 7, 2010) –  Network Services Company, an international organization of health care and janitorial supply distributors, recently announced the launch of Healthy Measures^™, a three-step consulting program to aid hospitals in the prevention of health care acquired infections (HAIs) while increasing patient satisfaction scores.

Partnering with health care facilities to assess their current conditions and cleaning practices, Healthy Measures (www.HealthyMeasuresOnline.com) is helping hospitals meet the standards and guidelines for housekeeping and hand hygiene recommended by the Centers for Disease Control and Prevention’s (CDC) Healthcare Infection Control Practices Advisory Committee (HICPAC).

“Infections pose an extreme risk to patients during a hospital stay, especially if the patient is already in a vulnerable condition,” said Kevin Rudd, Network Services’ chief marketing officer. “We’ve designed Healthy Measures to be an industry-leading solution that enables hospitals to reduce infection rates, thereby safeguarding patients and improving overall patient satisfaction.”

The CDC estimates there are approximately 100,000 deaths suffered annually in the U.S. stemming from an estimated two million preventable HAIs. Some of the pathogens that result in HAIs, which have been found to be readily transmitted from environmental surfaces to health care workers’ hands and to patients, include C. difficile (Clostridium difficile), methicillin-resistant S. aureus (MRSA), acinetobacter, norovirus and vancomycin-resistant enterococcus (VRE). But implementation of a hand hygiene and surface sanitation program like Healthy Measures can result in dramatically lower rates of infection.

The Healthy Measures program is a three-step process comprised of:

• Interviews with key personnel to gain an understanding of the facility’s current culture and challenges related to infection prevention;
• Facility assessment focusing on patient, public and staff areas to gain an understanding of current processes and procedures, and products used;
• Implementation of a comprehensive and customized joint-action plan related to hand hygiene and surface sanitation.

“The Healthy Measures Program provides a second pair of eyes when evaluating a facility and emphasizes collaboration by working closely with hospital staff to arrive at a solution,” said Rudd. “As part of the comprehensive solution, we provide checklists, educational and training materials, customizable signage, monthly tips, association guidelines, hospital rating websites and access to extensive research.”

Research indicates HAIs have become a financial risk to both individual health care facilities and the nation’s health care industry. The average cost of one HAI to a hospital is $14,000, while the average cost to the U.S. health care industry is between $4.5 and $5.7 billion annually (Source: Stone, et al. American Journal of Infection Control 2002; 30:145-52).

“Disinfection of the hospital environment and patient care equipment are essential strategies to prevent the spread of HAIs,” said Blake Kite, director of environmental services at Banner Estrella Medical Center. “One of the biggest things that impressed me about Healthy Measures was that we could decide upon our own action plan. We felt included in the process and part of the solution.”

About Network Services Company
Schaumburg, Ill.-based Network Services Company is a member-owned distribution network of more than 75 member-distributors with combined annual revenue of more than $12 billion. Members include distributors of janitorial supplies and equipment, as well as foodservice disposables and industrial packaging supplies and equipment. For more information about Network Services, please visit www.nsconline.com.

Click here to see all recent news from this company